Pathways Picks June 24: EU Standards Disarray, Reimbursement Reads, FDA on Pace

article image

In this week’s roundup: EU standards groups deal a blow to MDR rollout, wound-care tech gets mixed support in advance of coverage proposal, FDA touts no major review slowdowns amid COVID challenges, but warns that may not last.

The EU standards organizations formally rejected the Europe Commission’s request to align existing international standards with the oncoming Medical Device and IVD Regulations. That news leads this week’s Pathways’ Picks.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: